CSIMarket
 


Lifeloc Technologies Inc   (LCTC)
Other Ticker:  
 

Cumulative Lifeloc Technologies Inc 's Long Term Debt to Equity for Trailing Twelve Months Period

LCTC's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

LCTC Long Term Debt to Equity for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth 1.43 % -1.73 % -5.65 % -6.65 % -8.26 %
Y / Y Long Term Debt Growth -3.98 % -3.91 % -3.83 % -3.78 % -3.79 %
Long Term Debt to Equity for Trailing Twelve Months Period 0.19 0.2 0.2 0.2 0.2
Total Ranking # 822 # 885 # 923 # 1077 # 1003
Seq. Equity Growth 1.78 % 0.9 % -0.87 % -0.37 % -1.39 %
Seq. Long Term Debt Growth -1.04 % -1.03 % -0.99 % -0.98 % -0.97 %


Long Term Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to long-term debt repayement of -1.04% Lifeloc Technologies Inc decreased Long Term Debt to Equity for Trailing Twelve Months Period in the III. Quarter to 0.19, a new company low.
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Laboratory Analytical Instruments industry 3 other companies have achieved lower Long Term Debt to Equity for Trailing Twelve Months Period than Lifeloc Technologies Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is LCTC selling?
Long Term Debt to Equity LCTC in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 4
Sector # 142
S&P 500 # 810


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.24 0.21 0.19
(Dec 31 2017)   (Jun 30 2022)




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Laboratory Analytical Instruments Industry Long Term Debt to Equity for Trailing Twelve Months Period
Agilent Technologies inc   0.49 
Revvity Inc   0.45 
Codex Dna Inc   0.39 
Htg Molecular Diagnostics Inc  0.20 
Lifeloc Technologies Inc   0.20 
Illumina Inc   0.19 
Eyepoint Pharmaceuticals Inc   0.17 
Bio rad Laboratories Inc   0.14 
Phenomex Inc   0.08 
Singular Genomics Systems Inc   0.04 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com